Women with breast cancer have long faced complicated choices about the best course of treatment.
One particular concern has been the daily radiation therapy many women with breast cancer receive for six weeks after surgery. This form of therapy, also known as conventionally fractionated external beam radiation, has generally been recommended for most women undergoing breast conservation therapy. The goal has been to rid the body of any remaining cancerous cells that the surgeons tools could not remove.
Radiation, however, can be time-consuming and expensive for the patient and society. It also carries a small risk for late complications, such as heart disease.
New therapies have been tested that would shorten the length of radiotherapy from six weeks to three weeks, or deliver a single dose at the time of the lumpectomy procedure in the operating room.
A shorter course of radiation means more convenience, perhaps, fewer side effects and fewer out-of-pocket expenses. And a single dose of radiation is much cheaper than whole breast radiation therapy delivered over multiple weeks, but is associated with a slightly higher risk of local recurrence. So which option should patients and physicians choose?
In our recently published paper in the Journal of the National Cancer Institute, we came up with what we think is an answer. We showed through computer modeling that there is a better way for women and one that can save our health care system nearly US$100 million every year.
Problem and possible solutions
For decades, breast cancer was considered such a formidable foe that doctors who treated it and women who had it wanted to use everything in their arsenal to fight it.
That included the radical Halsted mastectomy, which often took out chest muscles along with the breast and left women disfigured.
It also included lengthy radiation treatments, sometimes for as long as seven weeks (known as conventionally fractionated radiation), given every day Monday through Friday after surgery. This form of radiation comes at great cost to women and causes hardships for those who live far away from radiation clinics.
In recent years, doctors studied new therapies for breast cancer. Halsted radical mastectomy has been replaced with a lumpectomy procedure that is usually performed on an outpatient basis. The radiation course has been shortened and is now delivered using sophisticated equipment, sparing unnecessary dose to the heart and lungs.
The better equipment also began to allow researchers to look at ways to shorten treatment. Hypofractionated radiation, in which a portion of the breast is treated for a shorter time, was one result.
Alternative therapies to conventional and hypofractionated radiation have also been recently introduced to deliver a single dose of radiation just to the tumor bed at the time of surgery. This is known is intraoperative radiotherapy, or IORT, meaning performed during the course of a surgical operation.
Given the availability of choices with overlapping costs and outcomes, clinicians always face a dilemma: Which treatment is best for my patient? Likewise, patients can ask their clinicians, Whats best for me? And, if both treatments are equally effective, is there a difference in price that might guide decisions?
Multiple randomized trials have shown that a 3- to 4-week course of whole breast radiation therapy is equivalent to a 6- to 8-week course. In fact, the National Comprehensive Cancer Network (NCCN) guidelines endorse the short hypofractionated course as the preferred approach.
Despite all this, American doctors have not widely adopted the new strategy. The reasons for this are varied, including dissemination of new findings to private practitioners and financial incentives of treating with a longer course. Our current fee-for-service reimbursement structure pays more for the longer treatment, which may be a factor in the surprisingly slow adoption of the convenient hypofractionated whole breast radiotherapy approach.
What might be adding more to this dilemma?
Clinical trials have compared these treatment choices with one another. Several large randomized trials have compared a 6-week course to a 3- to 4-week course of whole breast treatment and found that the two treatment approaches are equivalent in terms of cancer control. In fact, one trial found that the shorter course of treatment yielded lower rates of acute toxic effects compared to the longer course. Several randomized trials have compared conventionally fractionated radiation therapy to a single fraction intraoperative treatment just to the tumor bed at the time of surgery. Although extremely convenient, IORT was slightly worse at controlling cancer recurrence.
Yet, no single clinical trial has compared all three available options head-to-head. Another dilemma is that clinical trials usually follow patients for a period of five to 10 years, not a lifetime. That left an important question unanswered: How do we know which treatment is most beneficial over patient lifetime, and at what cost?
To solve this conundrum, we used computer modeling along with a cost-effectiveness analysis.
In our study, our interdisciplinary team tried to identify the most optimal radiation therapy that is, one that provides maximum value for money for women diagnosed with early stage breast cancer.
We simulated (created in computer) a hypothetical population of women diagnosed with early stage breast cancer. As per standard of care guidelines, women first get surgical treatment (lumpectomy).
Now comes the uncertainty! These hypothetical women can get either conventional whole breast radiation, hypofractionated radiation or one-time intraoperative radiation.
We obtained data from several clinical trials and databases to define treatment effectiveness and side effects, improvement or deterioration in quality of life, inconvenience (measures in term of travel time, lost wages, travel cost) and future consequences, including a possibility of cancer coming back or spreading to other organs.
In our simulation, we then followed these hypothetical women over their lifetime to identify which treatment strategy is most valuable, or cost-effective.
After extensive validation, we found that hypofractionated radiation is the most valuable treatment almost under all scenarios. It not only improves quality of life without compromising survival (adds four additional months of life with improved quality of health) but it also saves nearly $3,500 per patient.
We also learned that IORT, or radiation treatment at the time of operation, may be appropriate for older women who live far from radiation facilities and would have to endure hardship when traveling for daily whole breast radiation for three to four weeks.
Win-win for all! Our society saves health care dollars, and patients benefit most from treatment.
Our analysis showed that conventionally fractionated radiation, in which women receive the radiation over six weeks, is not cost-effective under any scenario and should not be considered as a choice by physicians or patients. Our study is the first to evaluate this using the latest available data.
A single dose of intraoperative radiation therapy, despite being much more convenient and less expensive, is associated with higher cancer recurrence rates. This difference in the risk of recurrence ends up costing the patient and society more than the hypofractionated treatment over a patients lifetime. Intraoperative radiation might be an option for older women who live in regions with poor access to health services. The shorter hypofractionated course is less expensive and improves quality of life substantially!
With growing health care costs and an aging population, we are starting to focus more and more on identifying treatments that are less expensive and equally effective. We found that the use of the optimal strategy in this situation has the potential to improve health outcomes and save at least $100 million every year.
Ashish A. Deshmukh, Assistant Professor, University of Florida and Anna Likhacheva, Adjunct assistant professor, The University of Texas MD Anderson Cancer Center
Read the rest here:
Why treating breast cancer with less may be more – Salon
- R&B Singer Keke Wyatt Reveals She Will Shave Her Head to Support Her Child Battling Cancer - PEOPLE.com - June 25th, 2017
- Emory Johns Creek offers new treatment of cancer tumors - Gwinnettdailypost.com - June 25th, 2017
- Community rallying around 36-year-old diagnosed with cancer on day her husband died - TwinCities.com-Pioneer Press - June 25th, 2017
- Teen Cancer Patient Fighting for Her Life, is Asking for Help in Meeting Justin Bieber - FOX40 - June 25th, 2017
- 5th annual Dragon Boat Festival empowers cancer survivors - wwlp.com - June 25th, 2017
- What Mormon Family Trees Tell Us About Cancer - The Atlantic - June 23rd, 2017
- Days after learning he had cancer, high school basketball star dies a day before graduation - Washington Post - June 23rd, 2017
- EU regulators greenlight US biotech Aveo's kidney cancer drug - Reuters - June 23rd, 2017
- Their little brother diagnosed with cancer, two boys raise money for others - USA TODAY - June 22nd, 2017
- Custom-built molecule shows promise as anti-cancer therapy - Phys.Org - June 22nd, 2017
- Caf Soul co-founder fighting to win against cancer - St. Louis American - June 22nd, 2017
- Greenville hospital to build teen cancer unit - The State - June 22nd, 2017
- Manchester gets UK's first high-energy proton beam cancer therapy machine - The Guardian - June 22nd, 2017
- Lowell High Head Martin hospitalized with bone cancer - Lowell Sun - June 22nd, 2017
- Grappling with cancers that break all the rules - STAT - June 22nd, 2017
- Oral Cancer Facts - The Oral Cancer Foundation - June 21st, 2017
- Could hair dyes, relaxers raise breast cancer risk? - Chicago Tribune - June 21st, 2017
- A New Approach to Safely Sharing Cancer Patients' Data - Harvard Business Review - June 21st, 2017
- Jets big man Mike Pennel, cancer survivor, 'watched by angels' - ESPN (blog) - June 21st, 2017
- Air pollution tied to survival odds for liver cancer patients - Reuters - June 21st, 2017
- Why pancreatic cancer is such a killer, and what's being done about it - CBS News - June 21st, 2017
- U2's The Edge talks up food as an anti-cancer weapon - The ... - Washington Post - June 21st, 2017
- Mum thought her baby girl had cancer after she was born with a lump that 'looked like a second head' - The Sun - June 21st, 2017
- Kalter: Cell migration study may be cancer breakthrough - Boston Herald - June 21st, 2017
- Sick fraudster who pretended she had cancer after researching symptoms and fitting her own DRIP is ordered to repay ... - The Sun - June 20th, 2017
- Half of all Canadians will get cancer in their lifetime, report says - Toronto Star - June 20th, 2017
- Nearly one in two Canadians expected to get cancer: report - The Globe and Mail - June 20th, 2017
- Treatment, not screening, credited with latest breast cancer advances - Pittsburgh Post-Gazette - June 20th, 2017
- New Cancer Treatment Uses Patient's Immune System To Fight Disease - CBS Pittsburgh / KDKA - June 20th, 2017
- Faces of the fighters against cancer - euronews - June 20th, 2017
- Dogs Will Sniff Out Stomach Cancer in New Japanese Trial - Smithsonian - June 20th, 2017
- Opinion: Three must-own cancer stocks for your biotechnology portfolio - MarketWatch - June 19th, 2017
- Battling and Buzzing off Cancer - wnep.com - June 19th, 2017
- Blood test could help personalise treatment for advanced prostate cancer - Cancer Research UK - June 19th, 2017
- Clovis's ovarian cancer drug set for label expansion, shares soar - Reuters - June 19th, 2017
- Had I talked James out of a cancer screening? If he'd gone, might it have been caught? - New Statesman - June 19th, 2017
- Discovery could guide immunotherapy for lung cancer - Cancer Research UK - June 19th, 2017
- My 6-Year-Old With Cancer May Never Get Health Insurance Again - Cosmopolitan.com - June 19th, 2017
- Cancer survivors unite at Foxboro Relay For Life - The Sun Chronicle - June 18th, 2017
- Experimental therapy that targets genes gives cancer patients hope - Tulsa World - June 18th, 2017
- Chattanooga Fire Department seeks spare gear to fight cancer risks - Chattanooga Times Free Press - June 18th, 2017
- Cancer studies of contaminated sites often reveal little proof - Albany Times Union - June 18th, 2017
- "Punch Out Cancer" Tournament Hits Home for SD Ireland Baseball - My Champlain Valley FOX44 & ABC22 - June 18th, 2017
- Minnesota soul singer Sonny Knight's second act cut short by cancer at 69 - Minneapolis Star Tribune - June 17th, 2017
- Study finds connection between breast cancer and hair products - AOL - June 17th, 2017
- Director John G. Avildsen dies of cancer; won Oscar for 'Rocky' - ESPN - June 17th, 2017
- Cancer survivor tells his story at Lombardi Walk to Tackle Cancer - WBAY - June 17th, 2017
- NY: 'Sham' cancer charity to close, pay $350000 after probe - ABC News - June 16th, 2017
- A Shared History of Cancer, a Love of Baseball and a Cubs-Mets Game - New York Times - June 16th, 2017
- More liver cancer deaths could be averted in the US - Reuters - June 16th, 2017
- What is liver cancer? Signs, symptoms, treatment and survival rate of the condition - The Sun - June 16th, 2017
- 90% of cancer deaths happen because it spreads. Researchers found clue to stopping it - Sacramento Bee - June 16th, 2017
- The Latest Cancer Research News to Cheer About - Parade - June 16th, 2017
- Higher Odds for Certain Cancers for Couch Potatoes - WebMD - June 16th, 2017
- Cancer's Big Infrastructure Problem - Forbes - June 16th, 2017
- Study shows how tech like Fitbit and Facebook could help childhood cancer survivors stay healthy - GeekWire - June 16th, 2017
- Man Who Dedicated Career To Fighting Cancer Now Battling Terminal Disease - CBS Philly - June 16th, 2017
- 'Monumental U-turn' on cancer drug - BBC News - June 16th, 2017
- MaineHealth cancer network gets $10 million grant from Harold Alfond Foundation - Press Herald - June 16th, 2017
- Johns Hopkins researchers say they've unlocked key to cancer metastasis and how to slow it - Baltimore Sun - June 16th, 2017
- School finds connection between breast cancer and hair products - New York's PIX11 / WPIX-TV - June 16th, 2017
- A Scientist Didn't Disclose Important Dataand Let Everyone Believe a Popular Weedkiller Causes Cancer - Mother Jones - June 16th, 2017
- Soccer Tournament Aims To Help Kids Battling Cancer - CBS Philly - June 15th, 2017
- These 5 Israeli advances could transform cancer treatment - Jewish Telegraphic Agency - June 15th, 2017
- What is testicular cancer? Signs, symptoms and treatment here's all you need to know - The Sun - June 15th, 2017
- Fran Drescher Links Uterine Cancer to Refusing to Confront Harrowing Rape 10 Years Before - PEOPLE.com - June 15th, 2017
- Relay draws families affected by cancer - Chicago Tribune - June 15th, 2017
- Tyler Henry Warns Khloe Kardashian About "Susceptibility" to Skin Cancer, Talks to Kylie Jenner About Unhealthy ... - E! Online - June 15th, 2017
- National Cancer Survivor Month - KXAN.com - June 15th, 2017
- Brother's dying wish leads to cancer benefit - Wichita Eagle - June 14th, 2017
- Science Says Get Moving to Avoid Increased Risk of Certain Cancers - Healthline - June 14th, 2017
- Drug that creates a 'real sun-tan' could prevent cancer - BBC News - June 14th, 2017
- After Investing in Robots and Edible Crickets, Dentsu Looks to Cure Cancer - AdAge.com (blog) - June 14th, 2017
- Radiologist still working despite scandal 'misses breast cancer' in another patient - The Independent - June 14th, 2017
- For experimental cancer therapy, a struggle to ensure supply keeps up with demand - Science Magazine - June 14th, 2017
- Scientists Look in the Toilet in Search for New Cancer Treatment - Bloomberg - June 14th, 2017
- Jerry Remy to undergo cancer treatment for second time in past six months - ESPN - June 13th, 2017
- Monday MLB scores, highlights, updates, news: Taillon back following cancer surgery - CBSSports.com - June 13th, 2017
- New Drugs Targeting Cancer 'Biomarkers' Could Revolutionize Care - Healthline - June 13th, 2017
- Mini Particle Accelerators Make Cancer Treatment Safer For Everyone - WIRED - June 13th, 2017